Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Navigation/Suche

• Forscher*innen.
• Institutionen.
• Projekte.
• Publikationen.
• Partner.
• Geldgeber.
• Ausstattung.
• Knowhow.
• Forschungsfelder.

Gewählte Publikation:

SHR Neuro Krebs Kardio Lipid Stoffw Microb

Kobayashi, H; Amrein, K; Mahmoud, SH; Lasky-Su, JA; Christopher, KB.
Metabolic phenotypes and vitamin D response in the critically ill: A metabolomic cohort study.
Clin Nutr. 2024; 43(11):10-19 Doi: 10.1016/j.clnu.2024.09.030
Web of Science PubMed FullText FullText_MUG

 

Co-Autor*innen der Med Uni Graz

Amrein Karin

Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:

BACKGROUND & AIMS: Although vitamin D deficiency is common in critically ill patients, randomized controlled trials fail to demonstrate benefits of supplementation. We aimed to identify distinct vitamin D₃ responsive metabolic phenotypes prior to trial intervention of high-dose vitamin D₃ by applying machine learning clustering method to metabolomics data from the Correction of Vitamin D Deficiency in Critically Ill Patients (VITdAL-ICU) trial. METHODS: In the randomized, placebo-controlled VITdAL-ICU trial, critically ill adults received placebo or high-dose vitamin D₃. To distinguish vitamin D₃ responsive metabolic phenotypes prior to intervention, we implemented consensus clustering with partitioning around medoids algorithm to the plasma metabolome data before randomization. Individual metabolite differences were determined utilizing linear mixed-effects regression models stratified for metabolomic phenotypes with false discovery rate adjustment. The association between vitamin D₃ supplementation and 180-day mortality was evaluated in each metabolic phenotype, applying multivariable logistic regression analysis. RESULTS: In 453 critically ill adults, the study identified 4 distinct metabolic phenotypes (clusters A. N = 134; B. N = 123; C. N = 92; D. N = 104). We found differential metabolic pathway patterns in the four clusters. Specifically, branched chain amino acid catabolic metabolites, long-chain acylcarnitines and diacylglycerol species are significantly increased in a specific metabolic phenotype (cluster D) following high-dose vitamin D₃. Further, in cluster D high-dose vitamin D₃ supplementation had a significantly lower adjusted odds of 180-day mortality after controlling age, sex, Simplified Acute Physiology Score II, admission diagnosis, and baseline 25-hydroxyvitamin D (OR 0.28 (95%CI, 0.09-0.89); P = 0.03). In metabotype A, B, and C, high-dose vitamin D₃ supplementation was not significantly associated with lower 180-day mortality following multivariable adjustment. CONCLUSION: In this post-hoc cohort study of the VITdAL-ICU trial, the clustering analysis of plasma metabolome data identified biologically distinct metabolic phenotypes. Among clusters, we found the different associations between high-dose vitamin D₃ supplementation and specific metabolite pathways as well as 180-day mortality. Our findings facilitate further research to validate metabolic phenotype-targeted strategies for critical illness treatments.

Find related publications in this database (Keywords)

Metabolomics

Critical illness

Heterogeneity

Phenotype

Vitamin D

Branched chain amino acids

© Med Uni Graz • Impressum